Results 91 to 100 of about 2,394 (185)
[Adverse reactions to drugs used for COVID-19 in five Latin American countriesReações adversas a medicamentos utilizados para a COVID-19 em cinco países da América Latina]. [PDF]
Orjuela-Rodríguez T +13 more
europepmc +1 more source
El SARS-Cov-2 ha provocado una cifra elevada de decesos, por ello, se ha investigado un tratamiento eficaz en las primeras etapas de la enfermedad, debido a la emergencia sanitaria, se buscan medicamentos aprobados por la FDA y que tengan actividad ...
Zárate Sánchez, María de la luz
core
Contenido y características de la ivermectina en fórmulas magistrales
Introducción: Tras la declaración de la COVID-19 como pandemia, la búsqueda de tratamientos se intensificó. En Perú, la ivermectina se propuso como tratamiento inicial por su supuesta seguridad, recomendándose para reducir la carga viral.
Jenny Rosalyn Huerta León +6 more
doaj
As doenças parasitológicas aliadas à resistência dos piolhos a fármacos comumente utilizados são consideradas grandes causas de quedas na produtividade dos rebanhos ovinos no Nordeste do Brasil.
Duarte, Vanessa Maria de Sales
core
[Cutaneous larva migrans in a traveler]. [PDF]
Villagrasa-Boli P +2 more
europepmc +1 more source
[Responsible use of antibiotics in COVID-19: To the gates of a new pandemic!!] [PDF]
Moyano LM +3 more
europepmc +1 more source
[Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone]. [PDF]
Feria L, Torrado M, Anton-Vazquez V.
europepmc +1 more source
Uporaba ivermectina u potpornoj terapiji oralne mijaze
Oral myiasis is generally associated to poor oral hygiene, alcoholism, senility, suppurative lesions, and neoplasia and has been constantly reported in elderly patients and/or patients with mental disorders and special needs. Different methods have been described for the clinical treatment of human myiasis, however, none of them were completely ...
Conto, Ferdinando De +6 more
openaire +1 more source
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital. [PDF]
Rodríguez-Tanta LY +5 more
europepmc +1 more source

